Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease
NCT02370524
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer's Disease (AD)
Interventions
DRUG:
[18F]T807
Sponsor
Molecular NeuroImaging
Collaborators
[object Object]
[object Object]